Healthcare IT Today
DECEMBER 6, 2024
As precision medicine becomes more nuanced and complex, biopharmaceutical companies are increasingly turning to AI to enhance the utility, performance, and scalability of computational pathology analyses for drug development and diagnostics. Aignostics is funded by leading investors and has operations in Berlin and New York.
Digital Health Global
JUNE 20, 2023
Founded in 2018 and supported from the outset by LallianSe, the life sciences integrator, BrainTale has developed and commercializes an accessible, reliable and clinically validated brain measurement digital platform solution for drug developers and physicians – neurologists, neuroradiologists and intensivists.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
NOVEMBER 20, 2023
We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale, provides a real opportunity to fundamentally improve patient care, drive healthcare transformation and reduce carbon emissions.” 2 Digital health is a large (+$900bn by 2032) and growing (13.6%
Lloyd Price
MAY 18, 2021
A new medication is introduced to the market via legislation rather than through formal drug development practices (3); 3. We see a reversal of the trend towards single molecule drug development in favour of the use of raw botanical products containing complex chemovars. 2018 Jun; 30(3): 277–284. Drug Metab.
Insulin Nation
NOVEMBER 27, 2018
In his studies, Type 1 diabetic patients have significantly benefited when their daily insulin regimen is supplemented with drugs developed to treat Type 2 diabetes. This was the first research ( release ) on using this Type 2 approved drug for T1D treatment and there were larger confirmatory studies ( release ) in 2016 and 2018.
mHealth Insight
APRIL 24, 2018
On Thursday the 26th April 2018 we’ll be presenting on Mobile First Clinical Trial Design at the Global Clinical Trials Connect 2018 Conference in London. Max Woolley, R&D Manager, Pre-Clinical Lead, Drug Delivery, Device Design & Development, Renishaw. Cases of failures, cost and delay are high.
DrKumo Remote Patient Monitoring
APRIL 12, 2022
Though the drug metformin (a biguanide formed by the fusion of two guanidines) was developed in 1922 by Wermer and Bell, it was the efforts of the French physician Jean Sterne that paved the way for the use of metformin as a glucose-lowering drug. 2018; 137:422–424. Cardiovascular diabetology, 18(1), 96. and Lang, C.
Expert insights. Personalized for you.
78 
Let's personalize your content